Results for tag: "Dopaminergic System Antagonist"

The Dopaminergic System Antagonist market is a subset of the Central Nervous System Drugs market. It is composed of drugs that act as antagonists to the dopaminergic system, which is responsible for controlling movement, emotion, cognition, motivation, and reward-seeking behavior. These drugs are used to treat a variety of conditions, including schizophrenia, bipolar disorder, and Tourette's syndrome. They are also used to treat Parkinson's disease, a neurological disorder characterized by tremors, stiffness, and difficulty with movement. The Dopaminergic System Antagonist market is highly competitive, with a number of major pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Novartis, GlaxoSmithKline, Merck, and Johnson & Johnson. Other companies, such as Teva Pharmaceuticals, Sun Pharmaceuticals, and Mylan, also have a presence in the market. Show Less Read more